home · filing · 0000081362-24-000106
8-K
filed July 31, 2024, 7:59 PM ET
ticker KWR
CIK 0000081362
leadership
confidence high
sentiment positive
materiality 0.30
Quaker Houghton appoints Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder to board
QUAKER CHEMICAL CORP
Board expanded from 10 to 12 directors; both appointed as independent members effective July 31, 2024.
Bakhshi, former President/CEO of Bank of the West, appointed to Audit and Sustainability Committees.
Foufopoulos-De Ridder, former EVP at Borealis Group, appointed to Compensation & HR and Sustainability Committees.
Compensation follows standard non-employee director program (annual cash retainer + RSUs) as disclosed in 2024 proxy.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Lucrèce Foufopoulos-De Ridder
Director
KWR ·
QUAKER CHEMICAL CORP
Effective 2024-07-31
Filed July 31, 2024, 7:59 PM ET
elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.
Appointed
Nandita Bakhshi
Director
KWR ·
QUAKER CHEMICAL CORP
Effective 2024-07-31
Filed July 31, 2024, 7:59 PM ET
elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lucrèce Foufopoulos-De Ridder was elected as Director at QUAKER CHEMICAL CORP.
Action elected
Role Director
Exact text from the filing
elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Nandita Bakhshi was elected as Director at QUAKER CHEMICAL CORP.
Action elected
Role Director
Exact text from the filing
elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.
View on SEC.gov
Source: SEC EDGAR
accession 0000081362-24-000106
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.